Yonsei Medical Center hosts the 'Global Digital Healthcare Symposium' on the 27th
Aug 04, 2024
Yonsei University Medical Center will hold the "2024 Global Healthcare Symposium" jointly with Naver Cloud Co., Ltd. (CEO Kim Yoo-won).
The event will be held on the 27th of this month at the only hall on the first floor of the Ebison Life Research Center at Yonsei University School of Medicine. The event, which begins at 9:30 a.m., runs until 5 p.m. Anyone who wishes to participate can attend for free after pre-registration by the 23rd.
The symposium will share research results under the theme of technology development and commercialization of digital treatment devices (DTx), confirm precedents by the number of digital treatment devices abroad, and share the latest industrial trends and strategies.
The event, which begins with the opening speech of Lim Joon-seok, head of the Digital Health Department at Yonsei Medical Center, will be followed by the announcement of 'Naver Cloud AI & Digital Healthcare' by Lee Sang-woo, director of Naver Cloud.
Afterwards, Masashi Misawa, a professor at the North Yokohama Hospital Center of Showa University in Japan, and Anne Sophie Geier, director of the German Digital Healthcare Association, will share information related to the approval of the number of digital treatment devices in the country, respectively.
Professor Lee Eun-eun of Yonsei University's School of Psychiatry, Han Young-min of the Ministry of Food and Drug Safety, and Kim Gun-so will also give lectures on prescription cases for digital treatment device platforms, clinical trial considerations, and design. Finally, a panel discussion order was prepared on what should be considered for approval and commercialization of digital treatment devices.
Lim Joon-seok, Director of Digital Health at Yonsei Medical Center, said, `This symposium will contribute to the remarkable development of the digital healthcare industry by providing opportunities for information exchange and networking among domestic and foreign industries, academia, research institutes, and hospitals.'We hope that it will be an opportunity to actively share valuable opinions through the interest and participation of many people interested in the digital healthcare field.'
Lee Sang-woo, director of Naver Cloud Co., Ltd., stressed that "This symposium will be of great help in understanding the current trends and implications of digital treatment devices" and that "Naver Cloud Co., Ltd. will also contribute to the creation of a safe and efficient digital healthcare environment."
The event will be held on the 27th of this month at the only hall on the first floor of the Ebison Life Research Center at Yonsei University School of Medicine. The event, which begins at 9:30 a.m., runs until 5 p.m. Anyone who wishes to participate can attend for free after pre-registration by the 23rd.
The symposium will share research results under the theme of technology development and commercialization of digital treatment devices (DTx), confirm precedents by the number of digital treatment devices abroad, and share the latest industrial trends and strategies.
The event, which begins with the opening speech of Lim Joon-seok, head of the Digital Health Department at Yonsei Medical Center, will be followed by the announcement of 'Naver Cloud AI & Digital Healthcare' by Lee Sang-woo, director of Naver Cloud.
Afterwards, Masashi Misawa, a professor at the North Yokohama Hospital Center of Showa University in Japan, and Anne Sophie Geier, director of the German Digital Healthcare Association, will share information related to the approval of the number of digital treatment devices in the country, respectively.
Professor Lee Eun-eun of Yonsei University's School of Psychiatry, Han Young-min of the Ministry of Food and Drug Safety, and Kim Gun-so will also give lectures on prescription cases for digital treatment device platforms, clinical trial considerations, and design. Finally, a panel discussion order was prepared on what should be considered for approval and commercialization of digital treatment devices.
Lim Joon-seok, Director of Digital Health at Yonsei Medical Center, said, `This symposium will contribute to the remarkable development of the digital healthcare industry by providing opportunities for information exchange and networking among domestic and foreign industries, academia, research institutes, and hospitals.'We hope that it will be an opportunity to actively share valuable opinions through the interest and participation of many people interested in the digital healthcare field.'
Lee Sang-woo, director of Naver Cloud Co., Ltd., stressed that "This symposium will be of great help in understanding the current trends and implications of digital treatment devices" and that "Naver Cloud Co., Ltd. will also contribute to the creation of a safe and efficient digital healthcare environment."
|
bellho@sportschosun.com
